XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative effect of newly adopted accounting standards
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative effect of newly adopted accounting standards
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2019       62,574,961 62,574,961          
Beginning balance at Dec. 31, 2019 $ 1,782,485 $ (34) $ 1,782,451 $ 626 $ 626 $ 1,348,733 $ 1,348,733 $ 433,126 $ (34) $ 433,092
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income 36,760             36,760    
Shares issued under stock-based compensation programs, net (in shares)       477,582            
Shares issued under stock-based compensation programs, net 8,194     $ 5   8,189        
Cash dividends declared (20,768)             (20,768)    
Stock-based compensation expense 4,440         4,440        
Forfeiture of restricted stock (in shares)       (48)            
Ending balance (in shares) at Mar. 31, 2020       63,052,495            
Ending balance at Mar. 31, 2020 1,811,077     $ 631   1,361,362   449,084    
Beginning balance (in shares) at Dec. 31, 2019       62,574,961 62,574,961          
Beginning balance at Dec. 31, 2019 1,782,485 $ (34) $ 1,782,451 $ 626 $ 626 1,348,733 $ 1,348,733 433,126 $ (34) $ 433,092
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income 220,094                  
Ending balance (in shares) at Sep. 30, 2020       64,865,577            
Ending balance at Sep. 30, 2020 1,987,999     $ 649   1,397,220   590,130    
Beginning balance (in shares) at Mar. 31, 2020       63,052,495            
Beginning balance at Mar. 31, 2020 1,811,077     $ 631   1,361,362   449,084    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income 84,396             84,396    
Shares issued under stock-based compensation programs, net (in shares)       334,178            
Shares issued under stock-based compensation programs, net (6,862)     $ 3   (6,865)        
Cash dividends declared (20,914)             (20,914)    
Stock-based compensation expense 5,488         5,488        
Forfeiture of restricted stock (in shares)       (1,807)            
Ending balance (in shares) at Jun. 30, 2020       63,384,866            
Ending balance at Jun. 30, 2020 1,873,185     $ 634   1,359,985   512,566    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income 98,938             98,938    
Shares issued under stock-based compensation programs, net (in shares)       1,480,711            
Shares issued under stock-based compensation programs, net 28,642     $ 15   28,627        
Cash dividends declared (21,374)             (21,374)    
Stock-based compensation expense 8,608         8,608        
Ending balance (in shares) at Sep. 30, 2020       64,865,577            
Ending balance at Sep. 30, 2020 $ 1,987,999     $ 649   1,397,220   590,130    
Beginning balance (in shares) at Dec. 31, 2020 64,851,126     64,851,126            
Beginning balance at Dec. 31, 2020 $ 2,119,912     $ 649   1,407,597   711,666    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income 110,690             110,690    
Shares issued under stock-based compensation programs, net (in shares)       221,303            
Shares issued under stock-based compensation programs, net 1,009     $ 2   1,007        
Cash dividends declared (25,978)             (25,978)    
Stock dividend declared (in shares)       5,192,776            
Stock dividend declared (687)     $ 52   279,579   (280,318)    
Stock-based compensation expense 9,926         9,926        
Ending balance (in shares) at Mar. 31, 2021       70,265,205            
Ending balance at Mar. 31, 2021 $ 2,214,872     $ 703   1,698,109   516,060    
Beginning balance (in shares) at Dec. 31, 2020 64,851,126     64,851,126            
Beginning balance at Dec. 31, 2020 $ 2,119,912     $ 649   1,407,597   711,666    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income $ 410,996                  
Ending balance (in shares) at Sep. 30, 2021 70,679,612     70,679,612            
Ending balance at Sep. 30, 2021 $ 2,457,984     $ 707   1,697,435   759,842    
Beginning balance (in shares) at Mar. 31, 2021       70,265,205            
Beginning balance at Mar. 31, 2021 2,214,872     $ 703   1,698,109   516,060    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income 154,352             154,352    
Shares issued under stock-based compensation programs, net (in shares)       358,993            
Shares issued under stock-based compensation programs, net (16,543)     $ 3   (16,546)        
Cash dividends declared (28,248)             (28,248)    
Stock-based compensation expense 8,126         8,126        
Forfeiture of restricted stock (in shares)       (4,560)            
Ending balance (in shares) at Jun. 30, 2021       70,619,638            
Ending balance at Jun. 30, 2021 2,332,559     $ 706   1,689,689   642,164    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income 145,954             145,954    
Shares issued under stock-based compensation programs, net (in shares)       69,512            
Shares issued under stock-based compensation programs, net (19)     $ 1   (20)        
Cash dividends declared (28,276)             (28,276)    
Stock-based compensation expense $ 7,766         7,766        
Forfeiture of restricted stock (in shares)       (9,538)            
Ending balance (in shares) at Sep. 30, 2021 70,679,612     70,679,612            
Ending balance at Sep. 30, 2021 $ 2,457,984     $ 707   $ 1,697,435   $ 759,842